drugset / Trial / NCT06593457

A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects

NCT06593457

Phase 1 Completed 32 enrolled Nurix Therapeutics, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a Phase 1, 2-part double-blinded (with respect to NX-5948/placebo), placebo-controlled study. Part 1 is a randomized, 3 period cross-over food-effect (FE) and drug-drug interaction (DDI) study. Part 2 is a single-period PK evaluation study.

Timeline

Start
2024-08-20
Primary completion
2024-10-29
Completion
2024-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule
Subject NX-5948 Other / unclassified Oral

Indications

No indication recorded.